Lin Yang

Publication Activity (10 Years)

Years Active: 2022-2024
Publications (10 Years): 13

Top Topics

Cancer Stem Cells

Editorial Comment

Top Venues

British journal of cancer

Clinical and translational medicine

This page only lists publications with an associated author ORCID identifier.

Publications

Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivitNot applicably to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivitNot applicably to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Correction: Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Correction: Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer (2024)
Lin Yang, Jiahong Yi, Wenzhuo He, Pengfei Kong, Qiankun Xie, Yanan Jin, Zhenchong Xiong, Liang-Ping Xia
Death receptors 4/5 mediate tumour sensitivity to natural killer cell-mediated cytotoxicity in mismatch repair deficient colorectal cancer. British journal of cancer 131 (2) (2024)
Zhenchong Xiong, Lin Yang, Ning Li, Jianchang Fu, Peng Liu, Peng Sun, Weidong Wei, Xiaoming Xie
DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clinical and translational medicine 12 (12) (2022)
Zhenchong Xiong, Lin Yang, Ning Li, Jianchang Fu, Peng Liu, Peng Sun, Weidong Wei, Xiaoming Xie
DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clinical and translational medicine 12 (12) (2022)
Zhenchong Xiong, Lin Yang, Ning Li, Jianchang Fu, Peng Liu, Peng Sun, Weidong Wei, Xiaoming Xie
DAB2IP attenuates chemoresistance of triple-negative breast cancer through sequestration of RAC1 to prevent β-catenin nuclear accumulation. Clinical and translational medicine 12 (12) (2022)